Establishment of a novel mesenchymal stem cell-based regimen for chronic myeloid leukemia differentiation therapy

Chronic myeloid leukemia (CML) is characterized by the accumulation of malignant and immature white blood cells which spread to the peripheral blood and other tissues/organs. Despite the fact that current tyrosine kinase inhibitors (TKIs) are capable of achieving the complete remission by reducing t...

Descripción completa

Detalles Bibliográficos
Autores principales: Zuo, Shiman, Sun, Luchen, Wang, Yuxin, Chen, Bing, Wang, Jingyue, Ge, Xiangyu, Lu, Yan, Yang, Nanfei, Shen, Pingping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7904926/
https://www.ncbi.nlm.nih.gov/pubmed/33627636
http://dx.doi.org/10.1038/s41419-021-03499-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7904926/
https://www.ncbi.nlm.nih.gov/pubmed/33627636
http://dx.doi.org/10.1038/s41419-021-03499-w

Ejemplares similares